Cargando…

Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis

OBJECTIVES: The aim of this study was to explore outcomes in a cohort of dcSSc patients fulfilling eligibility criteria for stem cell transplantation (SCT) studies but receiving standard immunosuppression. METHODS: From a large single-centre dcSSc cohort (n = 636), patients were identified using the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spierings, Julia, Nihtyanova, Svetlana I, Derrett-Smith, Emma, Clark, Kristina E N, van Laar, Jacob M, Ong, Voon, Denton, Christopher P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071533/ https://www.ncbi.nlm.nih.gov/pubmed/34314500 http://dx.doi.org/10.1093/rheumatology/keab604

Ejemplares similares

Distinctive clinical phenotype of anti-centromere antibody-positive diffuse systemic sclerosis
por: Caetano, Joana, et al.
Publicado: (2018)

Anti-thymocyte globulin exposure in patients with diffuse cutaneous systemic sclerosis undergoing autologous haematopoietic stem cell transplantation
por: Chiu, Yu-Hsiang, et al.
Publicado: (2023)

Information preferences about treatment options in diffuse cutaneous systemic sclerosis: A Delphi consensus study
por: Spierings, Julia, et al.
Publicado: (2021)

Pathogenesis of systemic sclerosis associated interstitial lung disease
por: Nihtyanova, Svetlana I, et al.
Publicado: (2020)

Diffuse cutaneous systemic sclerosis following SARS-Co V-2 vaccination
por: Cole, Alice, et al.
Publicado: (2022)

Positron Emission Tomography to Improve Assessment of Interstitial Lung Disease in Patients With Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation
por: Broens, Bo, et al.
Publicado: (2022)

Treatment decision-making in diffuse cutaneous systemic sclerosis: a patient’s perspective
por: Spierings, Julia, et al.
Publicado: (2020)

B-cell depletion with rituximab: a promising treatment for diffuse cutaneous systemic sclerosis
por: van Laar, Jacob M
Publicado: (2010)

Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature
por: Derrett-Smith, Emma C., et al.
Publicado: (2017)

The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosis
por: Derrett-Smith, Emma, et al.
Publicado: (2021)

Second autologous haematopoietic stem cell transplantation in systemic sclerosis—a case report
por: van Rhijn-Brouwer, Femke C C, et al.
Publicado: (2019)

Integrated analysis of dermal blister fluid proteomics and genome-wide skin gene expression in systemic sclerosis: an observational study
por: Clark, Kristina E N, et al.
Publicado: (2022)

Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need
por: Herrick, Ariane L., et al.
Publicado: (2022)

Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis
por: Cole, Alice, et al.
Publicado: (2022)

Patient perception of disease burden in diffuse cutaneous systemic sclerosis
por: Khanna, Dinesh, et al.
Publicado: (2019)

The role of innate immune cells in systemic sclerosis in the context of autologous hematopoietic stem cell transplantation
por: Servaas, N. H., et al.
Publicado: (2020)

Single-cell analysis reveals key differences between early-stage and late-stage systemic sclerosis skin across autoantibody subgroups
por: Clark, Kristina Elizabeth Neergaard, et al.
Publicado: (2023)

Clinical trial protocol: PRednisolone in early diffuse cutaneous Systemic Sclerosis (PRedSS)
por: Herrick, Ariane L, et al.
Publicado: (2020)

Management of systemic sclerosis: British Society for Rheumatology guideline scope
por: Denton, Christopher P, et al.
Publicado: (2023)

Relapsing polychondritis in systemic sclerosis: A rare vasculitic mimic
por: Teles, Carolina, et al.
Publicado: (2023)

Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)
por: Herrick, Ariane L, et al.
Publicado: (2017)

Autologous stem-cell transplantation in systemic sclerosis-associated interstitial lung disease: early action in selected patients rather than escalation therapy for all
por: Spierings, J., et al.
Publicado: (2021)

Nearest Consensus Clustering Classification to Identify Subclasses and Predict Disease
por: Alyousef, Awad A., et al.
Publicado: (2018)

A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol
por: Spierings, Julia, et al.
Publicado: (2021)

Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study
por: Peytrignet, Sébastien, et al.
Publicado: (2018)

Factors influencing early referral, early diagnosis and management in patients with diffuse cutaneous systemic sclerosis
por: Distler, Oliver, et al.
Publicado: (2018)

Exploring molecular pathology of chronic kidney disease in systemic sclerosis by analysis of urinary and serum proteins
por: Stern, Edward P, et al.
Publicado: (2021)

Resetting the T Cell Compartment in Autoimmune Diseases With Autologous Hematopoietic Stem Cell Transplantation: An Update
por: Lutter, Lisanne, et al.
Publicado: (2018)

From “being at war” to “getting back on your feet”: A qualitative study on experiences of patients with systemic sclerosis treated with hematopoietic stem cell transplantation
por: Spierings, Julia, et al.
Publicado: (2020)

Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality
por: De Almeida Chaves, Sébastien, et al.
Publicado: (2021)

Severe gangrene in a patient with anti-RNP positive limited cutaneous systemic sclerosis/rheumatoid arthritis overlap syndrome caused by vasculopathy and vasculitis
por: Raine, Charles, et al.
Publicado: (2018)

Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosis
por: Fox, David A., et al.
Publicado: (2021)

AZD-1222: Diffuse cutaneous systemic sclerosis: case report
Publicado: (2022)

Linking Medicare-Medicaid Claims for Patient-Centered Outcomes Research Among Dual-Eligible Beneficiaries
por: Jones, Kelley A., et al.
Publicado: (2023)

Dysregulated B cell function and disease pathogenesis in systemic sclerosis
por: Beesley, Claire F., et al.
Publicado: (2023)

Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma
por: Vugts, Jaynee J. A., et al.
Publicado: (2020)

Induction Treatment in Transplant-eligible Multiple Myeloma
por: Quinn, J., et al.
Publicado: (2021)

The Yin and Yang of IL-17 in Systemic Sclerosis
por: Wei, Lanxuan, et al.
Publicado: (2022)

Correction to: Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosis
por: Fox, David A., et al.
Publicado: (2021)

Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials
por: van Eijk, Ruben P.A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1ok0inj518tetmbr11adk7m4b6